Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
45%

OVERLAP
BY WEIGHT
11

# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
41%
ALSO IN XLV
XLV
60
HOLDINGS
18%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus XLV)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in XLV
Overlap
ELI LILLY & CO 20.3% 16.2% 16.2%
ABBVIE INC 10.0% 7.7% 7.7%
JOHNSON & JOHNSON 5.9% 9.9% 5.9%
MERCK & CO. INC. 4.4% 5.4% 4.4%
AMGEN INC 4.8% 3.7% 3.7%
MEDX Overweight Relative to XLV
NOVARTIS AG-ADR 7.0%
ASTRAZENECA PLC 4.8%
ALKERMES PLC 4.7%
ELI LILLY & CO 4.1%
BIOGEN IDEC INC 2.9%
GLAXOSMITHKLINE PLC-SPON ADR 2.5%
CRISPR THERAPEUTICS AG 2.4%
ABBVIE INC 2.3%
BRISTOL-MYERS SQUIBB CO 2.3%
IONIS PHARMACEUTICALS, INC. 2.2%
MEDX Underweight Relative to XLV
UNITEDHEALTH GROUP INC -5.3%
JOHNSON & JOHNSON -4.0%
THERMO FISHER SCIENTIFIC INC -3.8%
GILEAD SCIENCES INC -3.1%
ABBOTT LABORATORIES -2.8%
INTUITIVE SURGICAL INC -2.4%
DANAHER CORP -2.2%
VERTEX PHARMACEUTICALS INC -2.1%
MEDTRONIC PLC -1.9%
MCKESSON CORP -1.8%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY